Cargando…
Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine
With a prevalence of 15%, migraine is the most common neurological disorder and among the most disabling diseases, taking into account years lived with disability. Current oral medications for migraine show variable effects and are frequently associated with intolerable side effects, leading to the...
Autores principales: | Andreou, Anna P., Leese, Charlotte, Greco, Rosaria, Demartini, Chiara, Corrie, Eve, Simsek, Deniz, Zanaboni, Anna, Koroleva, Ksenia, Lloyd, Joseph O., Lambru, Giorgio, Doran, Ciara, Gafurov, Oleg, Seward, Elizabeth, Giniatullin, Rashid, Tassorelli, Cristina, Davletov, Bazbek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116399/ https://www.ncbi.nlm.nih.gov/pubmed/33205382 http://dx.doi.org/10.1007/s13311-020-00967-7 |
Ejemplares similares
-
Nonparalytic botulinum molecules for the control of pain
por: Mangione, Antonina S., et al.
Publicado: (2016) -
Botulinum neurotoxin type C protease induces apoptosis in differentiated human neuroblastoma cells
por: Rust, Aleksander, et al.
Publicado: (2016) -
A Cell Line for Detection of Botulinum Neurotoxin Type B
por: Rust, Aleksander, et al.
Publicado: (2017) -
Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing
por: Greco, Rosaria, et al.
Publicado: (2018) -
New botulinum neurotoxin constructs for treatment of chronic pain
por: Leese, Charlotte, et al.
Publicado: (2023)